Gestational trophoblastic diseases (GTD) comprise several entities which all arise due to abnormal growth of trophoblastic cells of the placenta. These disease processes range from benign to malignant. GTD are classified as complete hydatidiform mole, partial mole, invasive mole and choriocarcinoma. The imaging of choice for detecting trophoblastic disease is B-mode ultrasonography and color Doppler. When ultrasonography corresponds with the classic clinical presentation, accurate diagnosis is possible in a majority of cases of GTD. This article goes through several cases of GTD. Each case will demonstrate and review the principles of ultrasound diagnosis of different forms of GTD and apply it to the presented case studies. With early and accurate diagnosis with the help of ultrasonography, the cure rate for GTD is high.
INTRODUCTION
Gestational trophoblastic disease (GTD) represents the set of diseases associated with abnormal development of placental tissue. These diseases include hydatidiform moles, invasive moles and trophoblastic neoplasms. The incidence rate of hydatidiform mole in the United States is approximately 0.5-1/1,000 pregnancies and the incidence rate is increased in women of Asian descent. 1, 2 Hydatidiform mole transformation into trophoblastic neoplasia occurs in about 16 to 20% of patients with complete mole and 0.5% of patients with partial mole. 3, 4 Additionally, risk factors for GTD include increased maternal age, previous molar pregnancy, previous abortions and smoking. 5 Typically GTD presents clinically in women as abnormal first trimester vaginal bleeding and enlarged uterus. In such cases, other differential diagnoses must be ruled out. Vaginal bleeding may arise from obstetric causes such as ectopic pregnancy or spontaneous abortion as well as of gynecologic etiology in cases of uterine fibroids or polyps. Ultrasound imaging has become standard protocol in aiding in diagnosis of vaginal bleeding and suspected GTD. Standard B-mode ultrasound is useful in detecting the presence of fetal pole and abnormal uterine masses, while color and pulsed Doppler sonography is effective in assessing blood flow through the uterine vasculature. These ultrasound modalities in combination provide a cost-effective and noninvasive screening tool which can then be followed up with tissue histology and computed tomography/magnetic resonance imaging (CT/MRI) imaging. At the same time, classic pelvic sonography has its limitations in producing a threedimensional (3D) view of the uterus, the physical maneuverability of the transvaginal probe, and its decreased effectiveness in obese patients. 6 In all cases of vaginal bleeding and uterine enlargement, pregnancy test is the paramount first step in diagnosis. Negative beta-hCG can usually exclude most cases of GTD, while significantly elevated levels are nearly pathognomonic for presence of GTD, although exceptions to the rule require clinical judgment on the need for additional studies. In the presence of positive beta-hCG findings, history and physical can provide a guide for further evaluation. Abnormal vaginal bleeding in pregnancy, nausea and vomiting, urinary symptoms and pelvic pain require additional evaluation. Similarly, significant physical exam findings include enlarged uterus, blood on speculum exam, or presence of adnexal masses. If there is suspicion for GTD, pelvic ultrasound is the most appropriate next step for further assessment.
CASE REPORTS

Case 1
A 25-year-old G1P0 presents with painless vaginal bleeding. Her last menstrual period was 14 weeks ago. On physical exam, her temperature is 36.8°C, pulse 90 beats per minute, blood pressure 180/145. Blood pressure is stabilized and pelvic exam shows a small amount of blood in the vagina and an enlarged nontender uterus with normal adnexa. Doppler ultrasound reveals no fetal heart tones. Her betahCG was 290,000 mIU/ml (normal: 13,300-254,000 mIU/ ml). 3D ultrasound reveals fetal pole with absent heart activity and hydropic changes of the placenta (Fig. 1) . Evacuation of products of conception was performed and the specimen was sent for cytogenetic analysis.
Case 2
An 18-year-old G2 P1 previously healthy Japanese woman at 16 weeks gestation based on LMP, presented to the ED with painless vaginal bleeding. The patient states she has been having worsening nausea and vomiting for the last few weeks and now is unable keep anything down. She also states she has had chest palpitations, which did not occur previous to her pregnancy. On physical exam, her temperature is 98.6°F (37.0°C), heart rate is 122 beats per minute, and blood pressure is 145/93. Abdominal and pelvic examination confirms a 20-week sized uterus with blood in the vaginal vault. Quantitative beta-hCG was 147,000 mIU/ml. Fetal Doppler tones are not auscultated. Ultrasound assessment of the uterus (Fig. 2) demonstrates multiple internal echoes consistent with a 'snowstorm' appearance in the uterus. No fetal pole was visualized. Ultrasound assessment of the ovaries demonstrated theca lutein cysts bilaterally (Fig. 3) . The patient was transfused for anemia, and vacuum extraction was performed. Genetic analysis was performed and revealed 46XX karyotype. The patient was monitored for bleeding, and postprocedural serial beta-hCG was performed to rule out the development of malignant disease.
Case 3
A 42-year-old G4 P3 presented at 15 weeks gestation with abnormal painless vaginal bleeding which started on the previous day. She states she is also feeling weak and nauseous and comments that this never occurred with her previous pregnancy. On exam, temperature is 97.9°F, heart rate is 98 beats per minute, and blood pressure is 159/90. Laboratory studies showed quantitative beta-hCG was 182,000 mIU/ml. On abdominal examination the fundus was at the umbilicus, inconsistent with gestational age. The thyroid was normal on palpation. The lung and heart examinations are unremarkable. B-mode ultrasound demonstrated snowstorm appearance of the uterus. No fetal pole was visualized. Color Doppler demonstrated prominent blood flow signals within the myometrial portion of the uterus (Fig. 4) . Color Doppler studies detected reduction of vascular impedance in the uterine arteries (Fig. 5 ). Genetic analysis revealed 46XY karyotype. (Fig. 8 ).
DSJUOG
Chest and abdominal X-ray reveal multiple densities in the patient's lung and liver.
CASE DISCUSSION Case 1: Partial Hydatidiform Mole
Genetic analysis of the evacuated products of conception demonstrates 69XXX karyotype. Painless vaginal bleeding with products of conception on ultrasound and 69XXX karyotype is highly suggestive of partial molar pregnancy. A partial mole is derived from the fertilization of a single ovum by two separate sperms, producing a triploid trophoblast with one maternal and two paternal sets of chromosomes. 7 The end result is a nonviable pregnancy with fetal tissue detectable on sonography. Unlike complete moles, partial moles have a lesser tendency to transform into a gestational trophoblastic neoplasm. 8 This classic presentation of partial molar pregnancy may range from asymptomatic enlarged uterus to painless vaginal bleeding in the first trimester, very similar signs as incomplete or missed abortion. 9 Although vital signs are usually stable, patients may present with hypertension due to the elevated beta-hCG levels and its structural similarity to thyroid stimulating hormone (TSH). 10 The patient in this case is a 25-year-old G1P0 at 14 weeks gestation with vaginal bleeding, hypertension and abnormal pelvic exam. As with both complete and partial The numerous randomly dispersed vessels typical for neovascularization molar pregnancies, pelvic ultrasound evaluation and betahCG measurement are the investigations of choice for diagnosis. These are important in ruling out incorrect dating and to look for viable intrauterine pregnancy. B-mode ultrasound reveals enlarged area of villous tissue along with presence of fetal pole. Thickened placenta relative to the size of the fetus and cystic spaces within the placenta were suggestive of partial mole. Color Doppler ultrasound shows zones of high vascularization around the trophoblast signifying enlargement of spiral arteries. However, Doppler ultrasound alone cannot be used to differentiate between complete and partial hydatidiform mole. 11 The combination of B-mode with the color Doppler ultrasound facilitates detection of fetal heart activity and fetal parts, which is important in ruling out differential diagnoses. The obvious benefit of 3D ultrasound imaging in this setting is in its improved spatial orientation and demonstration of multiplanar views, as shown in Figure 1 . It is important to note that partial moles may often be missed on first trimester sonogram as miscarriage; therefore, histologic exam is still necessary to correctly diagnose the presence of GTD. 12 In this case, the patient will receive dilatation and curettage procedure and RhoGAM after diagnosis if she is Rh-negative. She will be monitored for further bleeding, and postprocedural serial beta-hCG measurements should be followed for up to 2 years. 9 Early sonogram is also recommended for subsequent pregnancies due to this patient's increased risk of recurrent molar pregnancy.
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Case 2: Complete Hydatidiform Mole
The patient has a classic presentation for a molar pregnancy. Typically, the most affected patients are young (<20 years) and older (>40 years) reproductive ages, and in Asian, Latino, and Filipino populations. 14, 15 In Japan, the incidence of molar pregnancy is 2.0 per 1,000 pregnancies, which is approximately three times higher than the incidence in Europe or North America. 15 Vaginal bleeding in the first trimester of pregnancy is the most common presenting symptom in complete molar pregnancy, although passage of hydropic villi can occur. 16 Other clinical signs and symptoms include uterus too large for dates, which can be seen in approximately 25% of moles, pain from benign thecalutein cysts (20%), hyperemesis (10%), hyperthyroidism (5%), and hypertension due to early pre-eclampsia (5%). 17 There is a detectable beta-hCG in molar pregnancies, although notably higher than the values observed in normal pregnancy. The presence of these features in the first half of pregnancy and a beta-hCG level >100,000, can make the clinical suspicion of complete molar pregnancy high. 18 In addition, the tachycardia the patient in this case experiences is most likely attributed to hyperthyroidism. The effect on the thyroid is explained by the similarities between the structures of beta-hCG and TSH. The molecular structure of hCG is composed of  and  subunits and it is the alphasubunit of beta-hCG that is identical to TSH, LH and FSH. The potency of beta-hCG for TSH receptors is significantly less than TSH and therefore, extremely high levels of betahCG are required for an effect on thyroid function to be seen. 10 In order to establish the diagnosis, ultrasound is the imaging of choice. A complete hydatidiform mole has a characteristic 'snowstorm' appearance on ultrasound. This is caused by the presence of multiple hydropic villi. A complete hydatidiform mole is characterized by generalized swelling of the villous tissue, trophoblastic hyperplasia and with no fetal tissue present. 19 In addition to the ultrasound examination of the uterus the ovaries should be studied as well. It is of high importance due to the fact that approximately 20% of patients with a complete mole will have theca lutein cysts of the ovaries present. 11 Theca lutein cysts are related to hCG hyperstimulation of the ovaries. 16 Complete hydatidiform moles are diploid and completely derived from the paternal genome with a chromosomal constitution of 46XX. This occurs in the majority of cases (82-86%). 11 In those cases the complete mole arises from haploid sperm (monospermic) fertilization of an anuclear ovum and then reduplicates its own chromosomes, resulting in the 46XX karyotype. In less than 10% of cases, dispermic fertilization occurs and the complete mole results in either a 46XX or a 46XY karyotype. 20 Approximately, 8% of patients with complete mole will develop a malignant tumor after evacuation. 8 . Four values or more of beta-hCG plateaued over at least 3 weeks 2. An increase in hCG of 10% or greater for 3 or more values over at least 2 weeks 3. The histologic diagnosis of choriocarcinoma 4. Persistence of hCG 6 months after molar evacuation.
Case 3: Invasive Mole
In this case, the patient's clinical presentation of advanced maternal age, vaginal bleeding, hyperemesis gravidarum, signs of pre-eclampsia (in early pregnancy) and enlarged uterus demonstrate a classic presentation for a complete molar pregnancy. The presence of these features in the first half of pregnancy and a beta-hCG level >100,000 mIU/ml can make the clinical suspicion of molar pregnancy high.
DSJUOG
Ultrasound Imaging of Gestational Trophoblastic Disease
Ultrasound is the imaging of choice when molar pregnancy is suggested. In this case, color Doppler demonstrated prominent blood flow signals within the myometrial portion of the uterus. This finding is pathognomonic for invasive mole. Secondary to myometrial invasion, color Doppler studies detected reduction of vascular impedance in the uterine arteries. In many cases B-mode real-time scan is not sufficient for the diagnosis of invasive mole and estimation of the myometrial invasion. Instead, by using transvaginal color Doppler, trophoblastic invasion into myometrial tissue is recognized. It can be visualized as prominent color-coded zones in the myometrium and high velocity and low impedance blood flow pattern displayed by pulsed Doppler waveform analysis. 11 An invasive hydatidiform mole is a form of GTN that occurs due to abnormal proliferation of placental trophoblast. They are characterized by the presence of edematous chorionic villi with trophoblastic proliferation that invades into the myometrium of the uterus or to adjacent structures. 22 Invasive mole is unlike choriocarcinoma which is without the presence of chorionic villi. An invasive mole most commonly occurs after the evacuation of GTD. Although both complete and partial moles have the potential to become invasive, it is more common following complete moles. 23 The incidence of an invasive hydatidiform mole occurring after evacuation of a complete hydatidiform mole is 10 to 15%. 11 Invasive moles are rarely metastatic. Management of an invasive mole includes treatment with chemotherapy as well as continued monitoring of beta-hCG. Patients with GTN should be followed with weekly quantitative beta-hCG levels until normal for 3 consecutive weeks, then monthly for 12 months. 24 Dilation and curettage is not recommended due to the risk of uterine perforation.
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Case 4: Choriocarcinoma
Choriocarcinoma is a malignant neoplasm arising from gestational trophoblastic tissue. It is a rare disease occurring in about one in 50,000 deliveries. 4 It can present as painless vaginal bleeding after diagnosis of molar pregnancy or as abnormal bleeding several months following delivery, as seen in this patient. Histologically, choriocarcinomas are beta-hCG producing epithelial tumors with high vascularity and abnormal cell proliferation characteristic of malignant neoplasms. 7 In this patient, the beta-hCG and ultrasound findings are indicative of choriocarcinoma in the uterus. Furthermore, this woman presents with dyspnea, hemoptysis, abdominal pain, as well as jaundice. These manifestations are attributed to the hematogenous spread of the tumor to the lung and liver due to the high metastatic potential of choriocarcinomas, and warrant further investigations. 25 Chest X-ray and abdominal CT are the next appropriate steps in diagnosis due to her symptoms of hemoptysis and jaundice. 26 Head CT may be beneficial had she presented with neurologic symptoms in addition to her positive X-ray findings.
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This 22-year-old patient was eventually treated with hysterectomy, chemotherapy (etoposide, methotrexate and actinomycin D), and radiation therapy. Normally, follow-up management of choriocarcinoma consists of serial beta-hCG level monitoring over the next 3 years and patient should be placed on contraceptives for at least 1 year. 28 Color Doppler has also been shown to be an effective tool in predicting the resolution or persistence of choriocarcinoma post-treatment. 29, 30 Unfortunately, the patient in this case deceased 8 months after diagnosis.
